Referências
Principais artigos
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416.Texto completo Resumo
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020 Aug 14;71(4):e1-36.Texto completo Resumo
Artigos de referência
1. Good RC. Opportunistic pathogens in the genus mycobacterium. Annu Rev Microbiol. 1985;39:347-69. Resumo
2. Saito H, Tomioka H, Sato K, et al. Identification of various serovar strains of Mycobacterium avium complex by using DNA probes specific for Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol. 1990 Aug;28(8):1694-7.Texto completo Resumo
3. Rosenzweig DY. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Chest. 1979 Feb;75(2):115-9. Resumo
4. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis. 1995 Apr;20(4):954-63. Resumo
5. Horsburgh CR Jr, Mason UG, Farhi DC, et al. Disseminated infection with Mycobacterium avium-intracellulare: a report of 13 cases and a review of the literature. Medicine. 1985 Jan;64(1):36-48. Resumo
6. Rickman OB, Ryu JH, Fidler ME, et al. Hypersensitivity pneumonitis associated with Mycobacterium avium complex and hot tub use. Mayo Clin Proc. 2002 Nov;77(11):1233-7. Resumo
7. Akram SM, Attia FN. Mycobacterium avium intracellulare. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Jan 2020 [internet publication].Texto completo Resumo
8. O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis. 1987 May;135(5):1007-14. Resumo
9. Joshi W, Davidson PM, Jones PG, et al. Non-tuberculous mycobacterial lymphadenitis in children. Eur J Pediatr. 1989 Aug;148(8):751-4. Resumo
10. Horsburgh CR, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989 Jan;139(1):4-7. Resumo
11. Tumbarello M, Tacconelli E, de Donati KG, et al. Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies. Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):498-501. Resumo
12. Horsburgh CR Jr. Epidemiology of Mycobacterium avium complex. Lung Biol Health Dis. 1996;87:1-22.
13. von Reyn CF, Maslow JN, Barber TW, et al. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet. 1994 May 7;343(8906):1137-41. Resumo
14. Fordham von Reyn C, Arbeit RD, Tosteson AN, et al, and the International MAI Study Group. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. AIDS. 1996 Aug;10(9):1025-32. Resumo
15. Benson CA. Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis. 1994 Apr;18(suppl 3):S218-22. Resumo
16. Tsang AY, Denner JC, Brennan PJ, et al. Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates. J Clin Microbiol. 1992 Feb;30(2):479-84.Texto completo Resumo
17. Gray JR, Rabeneck L. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol. 1989 Dec;84(12):1521-4. Resumo
18. Stacey AR. Isolation of Mycobacterium avium-intracellulare-scrofulaceum complex from faeces of patients with AIDS. Br Med J (Clin Res Ed). 1986 Nov 8;293(6556):1194.Texto completo Resumo
19. Horsburgh CR. The pathophysiology of disseminated M. avium disease in AIDS. J Infect Dis. 1999 May;179(suppl 3):S461-5. Resumo
20. Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome: a clinicopathologic study. Chest. 1988 May;93(5):926-32. Resumo
21. Vankayalapati R, Wizel B, Samten B, et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis. 2001 Feb 1;183(3):478-84. Resumo
22. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996 Dec 26;335(26):1941-9.Texto completo Resumo
23. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest. 1998 Jun 1;101(11):2364-9.Texto completo Resumo
24. Haas DW, Lederman MM, Clough LA, et al. Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS. J Infect Dis. 1998 Jun;177(6):1746-9. Resumo
25. Engbaek HC, Vergmann B, Bentzon MW. Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. An analysis of Danish patients during the period 1962-1976. Eur J Respir Dis. 1981;62(2):72-83. Resumo
26. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989 Sep 28;321(13):863-8. Resumo
27. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416.Texto completo Resumo
28. US Department of Health and Human Services, Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Feb 2020 [internet publication].Texto completo
29. Uthman MM, Uthman OA, Yahaya I. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD007191.Texto completo Resumo
30. De Francesco MA, Colombrita D, Pinsi G, et al. Detection and identification of Mycobacterium avium in the blood of AIDS patients by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):551-5. Resumo
31. Vu TT, Daniel SJ, Quach C. Nontuberculous mycobacteria in children: a changing pattern. J Otolaryngol. 2005 Jun;34(suppl 1):S40-4. Resumo
32. Gilks CF, Brindle RJ, Mwachari C, et al. Disseminated mycobacterium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr. 1995 Feb 1;8(2):195-8. Resumo
33. Hanak V, Kalra S, Aksamit TR, et al. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med. 2006 Apr;100(4):610-5. Resumo
34. Sood A, Sreedhar R, Kulkarni P, et al. Hypersensitivity pneumonitis-like granulomatous lung disease with nontuberculous mycobacteria from exposure to hot water aerosols. Environ Health Perspect. 2007 Feb;115(2):262-6.Texto completo Resumo
35. Nightingale SD, Byrd LT, Southern PM, et al. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 1992 Jun;165(6):1082-5. Resumo
36. Kurowski R, Ostapchuk M. Overview of Histoplasmosis. Am Fam Physician. 2002 Dec 15;66(12):2247-52.Texto completo Resumo
37. Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020 Aug 14;71(4):e1-36.Texto completo Resumo
38. Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov;72(suppl 2):ii1-ii64.Texto completo Resumo
39. US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. 2016 [internet publication].Texto completo
40. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Mar 2019 [internet publication].Texto completo
41. US Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Jul 2018 [internet publication].Texto completo
42. US Food and Drug Administration. FDA drug safety communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].Texto completo
43. Mandell DL, Wald ER, Michaels MG, et al. Management of nontuberculous mycobacterial cervical lymphadenitis. Arch Otolaryngol Head Neck Surg. 2003 Mar;129(3):341-4.Texto completo Resumo
44. Wallace RJ, Brown BA, Griffith DE, et al. Clarithromycin regimens for pulmonary mycobacterium avium complex: the first 50 patients. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1766-72. Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal